Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: Dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)
Original languageEnglish
Article numberPMID 12419756
Pages (from-to)1810-1818
JournalAnnals of Oncology
Publication statusPublished - 2002

Cite this